Population Pharmacokinetics and Pharmacodynamics of Piperacillin/Tazobactam in Patients with Nosocomial Infections

[1] Wang H(2007)Pharmacodynamic target attainment of seven antimicrobials against Gram-negative bacteria collected from China in 2003 and 2004 Int J Antimicrob Agents 30 457-60

[2] Zhang B(2004)Relationship between pharmacokinetics and pharmacodynamics of beta-lactams and outcome Clin Microbiol Infect 10 998-undefined

[3] Ni Y(2003)Population pharmacokinetic analysis of nonlinear behavior of piperacillin during intermittent or continuous infusion in patients with cystic fibrosis Antimicrob Agents Chemother 47 547-undefined

[4] Kuti JL(1976)Prediction of creatinine clearance from serum creatinine Nephron 16 41-undefined

[5] Chen B(2009)Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patients Int J Antimicrob Agents 34 433-undefined

[6] Chen M(2009)High performance liquid chromatographic determination of plasma free and total tazobactam and piperacillin J Chromatogr B Analyt Technol Biomed Life Sci 877 88-undefined

[7] Nicolau DP(2001)Assessment of actual significance levels for covariate effects in NONMEM J Pharmacokinet Pharmacodyn 28 252-undefined

[8] Sadaba B(2005)Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous venovenous hemofiltration J Clin Pharmacol 45 176-undefined

[9] Azanza JR(2014)Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis J Antimicrob Chemother 69 189-undefined

[10] Campanero MA(2005)Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection J Antimicrob Chemother 56 395-undefined

[1] Wang H(2007)Pharmacodynamic target attainment of seven antimicrobials against Gram-negative bacteria collected from China in 2003 and 2004 Int J Antimicrob Agents 30 457-60

[2] Zhang B(2004)Relationship between pharmacokinetics and pharmacodynamics of beta-lactams and outcome Clin Microbiol Infect 10 998-undefined

[3] Ni Y(2003)Population pharmacokinetic analysis of nonlinear behavior of piperacillin during intermittent or continuous infusion in patients with cystic fibrosis Antimicrob Agents Chemother 47 547-undefined

[4] Kuti JL(1976)Prediction of creatinine clearance from serum creatinine Nephron 16 41-undefined

[5] Chen B(2009)Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patients Int J Antimicrob Agents 34 433-undefined

[6] Chen M(2009)High performance liquid chromatographic determination of plasma free and total tazobactam and piperacillin J Chromatogr B Analyt Technol Biomed Life Sci 877 88-undefined

[7] Nicolau DP(2001)Assessment of actual significance levels for covariate effects in NONMEM J Pharmacokinet Pharmacodyn 28 252-undefined

[8] Sadaba B(2005)Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous venovenous hemofiltration J Clin Pharmacol 45 176-undefined

[9] Azanza JR(2014)Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis J Antimicrob Chemother 69 189-undefined

[10] Campanero MA(2005)Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection J Antimicrob Chemother 56 395-undefined